Stock Alert: RedHill Biopharma Shares Up 23% In Pre-Market

Shares of RedHill Biopharma Ltd. (RDHL) are rising over 23% in pre-market today, after the company announced that the first patient with confirmed coronavirus (COVID-19) diagnosis has been dosed with the company's proprietary investigational new drug, opaganib (Yeliva, ABC294640)1, at a leading hospital in Israel.